Abeona Therapeutics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABEO research report →
About the company
Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa.
- CEO
- Vishwas Seshadri
- IPO
- 1980
- Employees
- 136
- HQ
- Cleveland, NY, US
Price Chart
- Market Cap
- $364.77M
- P/E
- 5.48
- P/S
- 25.09
- P/B
- 2.50
- EV/EBITDA
- 4.45
- Div Yield
- 0.00%
- Gross Margin
- 51.93%
- Op Margin
- -637.92%
- Net Margin
- 454.86%
- ROE
- 41.40%
- ROIC
- -50.87%
- Revenue
- $5.82M · 0.00%
- Net Income
- $71.18M · 211.69%
- EPS
- $1.34 · 186.45%
- Op Income
- $-89,448,000
- FCF YoY
- -44.20%
- 52W High
- $7.54
- 52W Low
- $4.00
- 50D MA
- $5.63
- 200D MA
- $5.20
- Beta
- 1.35
- Avg Volume
- 1.16M
Get TickerSpark's AI analysis on ABEO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Alland Leila | sell | 11,000 |
| Jun 16, 26 | Vasanthavada Madhav | other | 222 |
| Jun 15, 26 | Silverstein Christine Berni | sell | 18,160 |
| Jun 8, 26 | O'Malley Brendan M. | sell | 4,826 |
| Jun 9, 26 | O'Malley Brendan M. | sell | 6,305 |
| Jun 8, 26 | Vazzano Joseph Walter | sell | 10,271 |
| Jun 9, 26 | Vazzano Joseph Walter | sell | 13,421 |
| Jun 9, 26 | Vazzano Joseph Walter | sell | 25,646 |
| Jun 8, 26 | Vasanthavada Madhav | sell | 4,170 |
| Jun 9, 26 | Vasanthavada Madhav | sell | 5,450 |
Our ABEO coverage
Recent articles, reports, and earnings notes.
No research on ABEO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ABEO report →Similar companies
Peers in the same neighborhood.